REDHILL BIOPHARMA LTD-SP ADR
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.
Find out what a historical investment in REDHILL BIOPHARMA LTD-SP ADR would be worth today using our RDHL stock calculator.
$3.36M
-
0.00%
18.24K
$1.93
$1.82
$1.87
$20.28
$1.71
Ready to start your investing journey with Stake?
Open an accountRDHL FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RDHL
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RDHL
on Stake
Buy RDHL from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of RDHL from only US$10 with fractional shares
